Suchergebnisse - "Tavakolpour, Soheil"

PubPharm (37)

1

Rituximab for the treatment of epidermolysis bullosa acquisita : A large case series of 15 patients

enthalten in: Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG | 2023

von Dasdar, S. | Kianfar, N. | Tavakolpour, S. | +3

2

Elevated serum level of B-cell activating factor (BAFF) after rituximab therapy in pemphigus vulgaris patients suggests a possible therapeutic efficacy of B-cell depletion therapies combined with anti-BAFF agents

enthalten in: International journal of dermatology | 2023

von Daneshvar, E. | Tavakolpour, S. | Mahmoudi, H. | +4

3

Prevalence and management of chronic hepatitis B in pemphigus and pemphigoid patients : New evidence for the safety of rituximab

enthalten in: Dermatologic therapy | 2022

von Aryanian, Z. | Tahooneban, A. | Balighi, K. | +6

4

Retrospective study of gingival involvement in pemphigus : A difficult to treat phenomenon

enthalten in: Dermatologic therapy | 2022

von Balighi, K. | Shams-Davatchi, C. | Ghobadi, S. | +8

5

Rituximab monotherapy in mild pemphigus

enthalten in: The Journal of dermatological treatment | 2022

von Nili, A. | Mahmoudi, H. | Heidari, N. | +4

6

Rituximab in childhood and juvenile autoimmune bullous diseases as first-line and second-line treatment : a case series of 13 patients

enthalten in: The Journal of dermatological treatment | 2022

von Kianfar, N. | Dasdar, S. | Mahmoudi, H. | +3

7

Evaluating the risk-to-benefit ratio of using cotrimoxazole as a pneumocystis pneumonia preventative intervention among pemphigus patients treated with rituximab : A retrospective study with 494 patients

enthalten in: Dermatologic therapy | 2022

von Faraji, H. | Daneshpazhooh, M. | Ehsani, A. | +6

8

Pustular eruption after biosimilar rituximab infusion : report of acute generalized exanthematous pustulosis in two patients with pemphigus

enthalten in: International journal of dermatology | 2022

von Daneshpazhooh, M. | Tavakolpour, S. | Salehi Farid, A. | +4

9

A systematic review on efficacy, safety, and treatment-durability of low-dose rituximab for the treatment of Pemphigus : special focus on COVID-19 pandemic concerns

enthalten in: Immunopharmacology and immunotoxicology | 2021

von Tavakolpour, S. | Aryanian, Z. | Seirafianpour, F. | +6

10

The Paradoxical Reaction to Rituximab in Six Granulomatosis with Polyangiitis Patients : How Could it be Explained and Managed?

enthalten in: Current rheumatology reviews | 2021

von Alesaeidi, S. | Piri, S. | Tavakolpour, S.